L26/P-216 Less invasive strategies in trophectoderm biopsy: rethinking assisted hatching at the cleavage stage
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von E. De Martino und 14 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does the timing of assisted hatching (AH) affect blastocyst development, morphological quality, chromosomal status, and clinical outcomes in preimplantational genetic testing for aneuploidy (PGT-A) cycles? Summary answer Adopting less invasive strategies such as delayed assisted hatching results in comparable euploidy and clinical outcomes, with improved blastocyst morphology and lower miscarriage rates. What is known already To obtain a trophectoderm cell sample for PGT, the embryo’s zona pellucida must be breached to allow access to the cells. AH can be performed on day 3 or 4 of culture or at the time of trophectoderm biopsy. Premature breaching of the zona pellucida may introduce artefacts that interfere with the physiological process of zona thinning, potentially resulting in smaller-diameter blastocysts with thicker zonae. IVF laboratories adopt different protocols based on workflow and embryologist experience; however, the optimal timing of AH and its potential impact on embryo development and PGT outcomes remain unclear and controversial, with limited supporting evidence. Study design, size, duration This retrospective cohort study included 1,199 PGT-A cycles comprising 4,929 blastocysts, of which 4,782 were biopsied, performed at a single IVF center between May 2018 and October 2025. Biopsied embryos were classified into study groups according to the assisted hatching strategy applied prior to trophectoderm biopsy (early versus late assisted hatching). A total of 1,305 embryo transfers were performed. Cycles involving surgically retrieved sperm or PGT-M were excluded. Participants/materials, setting, methods Biopsied blastocysts were allocated to two groups: assisted hatching on day 3 with trophectoderm biopsy on days 5–7 (early hatching; n = 2,606) and assisted hatching performed at the time of biopsy (late hatching; n = 2,176). Outcomes assessed included the blastocyst formation rate, day of biopsy, blastocyst quality (Gardner A–D), euploidy rate, clinical pregnancy, implantation, and miscarriage rates. The statistical data analysis was conducted using the Chi-square test, with P < 0.05 considered significant. Main results and the role of chance The proportion of embryos available for biopsy was significantly higher in the early hatching group compared with late hatching (44.4% vs 40.8%; p < 0.001). A higher proportion of biopsies were performed on day 5 in the early hatching group (55.6% vs 41.7%; p < 0.001), whereas late hatching was associated with a shift toward later biopsy days (D6–D7). Euploidy rates were comparable between groups (41.8% vs 42.6%). In contrast, the proportion of high-quality blastocysts (Gardner grades A+B) was significantly higher in the late hatching group (54.6% vs 65.5%; p < 0.001). Clinical pregnancy rates were comparable between groups (46.3% vs 47%), as were implantation rates (47.0% vs 46.0%). However, miscarriage rates were significantly higher in the early hatching group compared with late hatching (17.8% vs 8.2%; p < 0.001). Overall, the timing of assisted hatching influenced blastocyst development and morphology, without affecting euploidy or pregnancy rates. Limitations, reasons for caution Early assisted hatching promotes trophectoderm herniation in early blastocysts and facilitates biopsy, whereas AH at the expanded blastocyst stage is physiologically appropriate but technically demanding. Limitations include the retrospective design and long study period, during which culture conditions, biopsy techniques, embryologist expertise and embryo selection strategies may have evolved. Wider implications of the findings Delaying assisted hatching until trophectoderm biopsy may represent a less invasive approach compatible with time-lapse incubators, without compromising euploidy or clinical pregnancy outcomes. Although early hatching facilitates earlier biopsy, it may be associated with reduced morphological quality and higher miscarriage rates. It’s important to optimize AH timing in biopsy protocols. Trial registration number No
Zitieren
APA
Martino, E. D., Passi, N., Kopcow, L., Papayannis, M., Filardi, P., Horton, M., Oubina, A., Sobral, F., Soberon, V., Magri, L., Sosa, M. C., Oubina, G., Justo, F., Zuniga, I. D., & Bisioli, C. (2026). L26/P-216 Less invasive strategies in trophectoderm biopsy: rethinking assisted hatching at the cleavage stage. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.552
Vancouver
Martino ED, Passi N, Kopcow L, Papayannis M, Filardi P, Horton M, et al. L26/P-216 Less invasive strategies in trophectoderm biopsy: rethinking assisted hatching at the cleavage stage. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.552
BibTeX
@article{Martino2026,
author = {Martino, E. De and Passi, N. and Kopcow, L. and Papayannis, M. and Filardi, P. and Horton, M. and Oubina, A. and Sobral, F. and Soberon, V. and Magri, L. and Sosa, M. Chiarello and Oubina, G. and Justo, F. and Zuniga, I. De and Bisioli, C.},
title = {L26/P-216 Less invasive strategies in trophectoderm biopsy: rethinking assisted hatching at the cleavage stage},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.552}
}
EUVIMED